Schmertzler Michael 的 Form 4 申報
PTC Therapeutics, Inc.（PTCT），2026/9/18 申報
- 申報編號
- 0001288952-26-000012
- 申報時間
- 2026/9/18 17:20 ET
- 交易日
- 2026/9/16-9/17
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 4 筆非衍生性交易。公開市場賣出合計 $135.0 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Schmertzler MichaelCIK 0001288952 | 董事 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $65.99 to $66.96 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $66.99 to $67.72 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $67.27 to $68.10 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.35 to $68.84 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。